What is the BioAffinity Technologies Inc. stock price forecast?

BioAffinity Technologies Inc. is currently trading at $0.29. View real-time AI analysis on Alpha Lenz.

What is BioAffinity Technologies Inc. insider trading activity?

View the latest insider trading data for BioAffinity Technologies Inc. on Alpha Lenz.

What is BioAffinity Technologies Inc.'s P/E ratio?

View BioAffinity Technologies Inc.'s valuation metrics on Alpha Lenz.

BioAffinity Technologies Inc.

NASDAQ · BIAFW

$0.29+0.00(+0.00%)Pre-market

Ask about BioAffinity Technologies Inc.'s future dividend policy...

Alpha Chat Insight

“BioAffinity Technologies Inc.'s ROE is -301.8%. Explore profitability and growth together.”

Ask for details →

Company Overview

BioAffinity Technologies Inc. is a biotechnology company dedicated to the development of novel diagnostics and therapeutic advancements. Primarily focused on early cancer detection and treatment, the firm utilizes cutting-edge technologies to enhance patient outcomes. A standout feature of BioAffinity Technologies is its pursuit of non-invasive testing solutions that aim to detect cancer at an early stage, thereby facilitating timely medical intervention. The company's innovative research and product development efforts greatly impact the healthcare and biotechnology sectors by potentially reducing the global burden of cancer. BioAffinity Technologies operates within the dynamic biotech industry, known for its rapid advancements and crucial role in improving public health. By integrating advanced scientific research with practical applications, BioAffinity Technologies Inc. plays a significant role in the quest for better diagnostic tools and cancer therapies, positioning itself as a noteworthy participant in the medical and scientific community.

CEOMs. Maria Zannes J.D.

Websitehttps://www.bioaffinitytech.com

SectorHealthcare

IndustryDiagnostics & Research

Employees57

Company Statistics

FY 2025

Profile

N/AMarket Cap

$6.11MRevenue

0.00Shares Out

57Employees

Margins

30.80%Gross

-172.01%EBITDA

-173.98%Operating

-243.38%Pre-Tax

-244.10%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

983.41%Rev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-170.65%ROA

-301.83%ROE

-169.63%ROIC

Financial Health

$6.45MCash & Cash Equivalents

$-2.77MNet Debt

50.61%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“BioAffinity Technologies Inc.'s ROE is -301.8%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

BioAffinity Technologies Inc. (ticker: BIAFW) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 57 employees.

The current price is $0.295 with a P/E ratio of -x and P/B of -x.

ROE is -301.83% and operating margin is -173.98%. Annual revenue is $6M.